CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
32.63
+0.39 (1.21%)
Nov 21, 2024, 2:05 PM EST - Market open
CG Oncology Employees
CG Oncology had 61 employees as of December 31, 2023.
Employees
61
Change
n/a
Growth
n/a
Revenue / Employee
$11,213
Profits / Employee
-$1,290,672
Market Cap
2.21B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 61 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Addus HomeCare | 34,846 |
| CONMED | 4,000 |
| Premier | 2,900 |
| Amphastar Pharmaceuticals | 1,761 |
| Alignment Healthcare | 1,536 |
| Wave Life Sciences | 268 |
| Keros Therapeutics | 136 |
| IDEAYA Biosciences | 124 |
CGON News
- 2 months ago - CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - GlobeNewsWire
- 3 months ago - CG Oncology: Promising Data, But Looks Expensive - Seeking Alpha
- 3 months ago - CG Oncology Reports Second Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 4 months ago - CG Oncology Bringing Undervalued Innovation To Bladder Cancer - Seeking Alpha
- 6 months ago - CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBC - GlobeNewsWire
- 6 months ago - CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive High-Risk NMIBC at ASCO 2024 Annual Meeting - GlobeNewsWire
- 7 months ago - CG Oncology Reports First Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 7 months ago - CG Oncology: ASCO Play And Top-Line Data End Of 2024 Could Drive Further Value - Seeking Alpha